This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Discover whether stocks or bonds are better for achieving financial freedom. Start making smarter investment decisions today.
26,067 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
The Ebola outbreak in the Democratic Republic of Congo has intensified as aid budgets shrink. Experts warn that the r...
A prominent quadruple amputee cornhole champion has been charged with murder following a fatal confrontation in Maryl...
A growing cohort of retiring small-business owners discovers decades of low salaries left smaller Social Security che...
A 2025 performance-year pay surge pushed the average wall street bonus to around $210,000, about three times the typi...
A growing cohort of dentists is turning to cash-balance plans to fund retirement beyond 401(k) limits, giving practic...
Investors are watching Crinetics' Q1 2026 results for clues on milestones, cash runway, and partnerships. This guide ...
Visa sits at the center of a rapidly evolving payments ecosystem. This article explains why Visa is considered a stro...
A pivotal Investor Day pushed Schwab stock higher on Friday as management raised guidance on revenue growth and net i...
Corporations are paying top dollar for battle-tested CFOs to steer turnarounds. Nike’s high-profile hire underscores ...
A public clash between TV host Jimmy Kimmel and RFK Jr. shows how media moments can influence budgets and spending. T...
A kansas city woman accused case shines a light on how income reporting affects SNAP eligibility. Learn how benefits ...